Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: the Bruneck study - PubMed (original) (raw)
Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: the Bruneck study
Enzo Bonora et al. Diabetes Care. 2007 Feb.
Abstract
Objective: The purpose of this study was to evaluate whether insulin resistance is associated to cardiovascular disease (CVD) and to understand whether this association can be explained by traditional and novel CVD risk factors associated with this metabolic disorder.
Research design and methods: We examined a sample representative of the population of Bruneck, Italy (n = 919; aged 40-79 years). Insulin-resistant subjects were those with a score in the top quartile of the homeostasis model assessment (HOMA) for insulin resistance (HOMA-IR). Risk factors correlated with insulin resistance included BMI, A1C, HDL cholesterol, triglycerides, blood pressure, high-sensitivity C-reactive protein (hsCRP), fibrinogen, oxidized LDL, vascular cell adhesion molecule-1 (VCAM-1), and adiponectin. Subjects without CVD at baseline were followed up for 15 years for incident CVD, a composite end point including fatal and nonfatal myocardial infarction and stroke, transient ischemic attack, and any revascularization procedure.
Results: During follow-up, 118 subjects experienced a first symptomatic CVD event. Levels of HOMA-IR were higher at baseline among subjects who developed CVD (2.8) compared with those remaining free of CVD (2.5) (P < 0.05). Levels of HOMA-IR also were significantly correlated (P < 0.05) with most CVD risk factors we evaluated. In Cox proportional hazard models, insulin-resistant subjects had an age-, sex-, and smoking-adjusted 2.1-fold increased risk (95% CI 1.3-3.1) of incident symptomatic CVD relative to non-insulin-resistant subjects. After sequential adjustment for physical activity and classic risk factors (A1C, LDL cholesterol, and hypertension) as well as BMI, HDL cholesterol, triglycerides, and novel risk factors, including fibrinogen, oxidized LDL, hsCRP, VCAM-1, and adiponectin, the association between HOMA-IR and incident CVD remained significant and virtually unchanged (hazard ratio 2.2 [95% CI 1.4-3.6], P < 0.001).
Conclusions: HOMA-estimated insulin resistance is associated with subsequent symptomatic CVD in the general population independently of all classic and several nontraditional risk factors. These data suggest that insulin resistance may be an important target to reduce CVD risk.
Similar articles
- HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study.
Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Cacciatori V, Santi L, Targher G, Bonadonna R, Muggeo M. Bonora E, et al. Diabetes Care. 2002 Jul;25(7):1135-41. doi: 10.2337/diacare.25.7.1135. Diabetes Care. 2002. PMID: 12087010 - Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study.
Hanley AJ, Williams K, Stern MP, Haffner SM. Hanley AJ, et al. Diabetes Care. 2002 Jul;25(7):1177-84. doi: 10.2337/diacare.25.7.1177. Diabetes Care. 2002. PMID: 12087016 - The plasma leptin/adiponectin ratio predicts first cardiovascular event in men: a prospective nested case-control study.
Kappelle PJ, Dullaart RP, van Beek AP, Hillege HL, Wolffenbuttel BH. Kappelle PJ, et al. Eur J Intern Med. 2012 Dec;23(8):755-9. doi: 10.1016/j.ejim.2012.06.013. Epub 2012 Jul 20. Eur J Intern Med. 2012. PMID: 22819464 - Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study.
Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson PW. Rutter MK, et al. Diabetes. 2005 Nov;54(11):3252-7. doi: 10.2337/diabetes.54.11.3252. Diabetes. 2005. PMID: 16249452 - Predictive Value of Insulin Resistance as Determined by Homeostasis Model Assessment in Acute Ischemic Stroke Patients: A Systematic Review and Meta-Analysis.
Wu A, Li Y, Liu R, Qi D, Yu G, Yan X, Mao D, Li X, Zhou R, Dai W. Wu A, et al. Horm Metab Res. 2021 Nov;53(11):746-751. doi: 10.1055/a-1648-7767. Epub 2021 Nov 5. Horm Metab Res. 2021. PMID: 34740276
Cited by
- In vivo actions of peroxisome proliferator-activated receptors: glycemic control, insulin sensitivity, and insulin secretion.
Eldor R, DeFronzo RA, Abdul-Ghani M. Eldor R, et al. Diabetes Care. 2013 Aug;36 Suppl 2(Suppl 2):S162-74. doi: 10.2337/dcS13-2003. Diabetes Care. 2013. PMID: 23882042 Free PMC article. Review. No abstract available. - Impaired insulin-stimulated myocardial glucose metabolic rate is associated with reduced estimated myocardial energetic efficiency in subjects with different degrees of glucose tolerance.
Succurro E, Cicone F, Papa A, Miceli S, Vizza P, Fiorentino TV, Perticone M, Sciacqua A, Guzzi PH, Veltri P, Cascini GL, Andreozzi F, Sesti G. Succurro E, et al. Cardiovasc Diabetol. 2023 Jan 9;22(1):4. doi: 10.1186/s12933-022-01733-z. Cardiovasc Diabetol. 2023. PMID: 36624469 Free PMC article. - IMPROVE, a community-based exercise intervention versus support group to improve functional and health outcomes among older African American and non-Hispanic White breast cancer survivors from diverse socioeconomic backgrounds: Rationale, design and methods.
Owusu C, Nock NL, Hergenroeder P, Austin K, Bennet E, Cerne S, Moore H, Petkac J, Schluchter M, Schmitz KH, Webb Hooper M, Atkins L, Asagba O, Wimbley L, Berger NA. Owusu C, et al. Contemp Clin Trials. 2020 May;92:106001. doi: 10.1016/j.cct.2020.106001. Epub 2020 Apr 15. Contemp Clin Trials. 2020. PMID: 32304828 Free PMC article. - Factors associated with no apparent coronary artery disease in patients with type 2 diabetes mellitus for more than 10 years of duration: a case control study.
Srinivasan MP, Kamath PK, Bhat NM, Pai ND, Manjrekar PA, Mahabala C. Srinivasan MP, et al. Cardiovasc Diabetol. 2015 Oct 31;14:146. doi: 10.1186/s12933-015-0307-z. Cardiovasc Diabetol. 2015. PMID: 26521236 Free PMC article. - Hyperinsulinemia and obese phenotype differently influence blood pressure in young normotensive patients with polycystic ovary syndrome.
Mioni R, Cà AD, Turra J, Azzolini S, Xamin N, Bleve L, Maffei P, Vettor R, Fallo F. Mioni R, et al. Endocrine. 2017 Feb;55(2):625-634. doi: 10.1007/s12020-016-0958-x. Epub 2016 May 3. Endocrine. 2017. PMID: 27142411
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous